Hardmeier, M <br/><br/>
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.  [electronic resource] 

 -  Neurology  Jan 2005 
 - 236-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/01.WNL.0000149516.30155.B8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Atrophy<br/>Brain--pathology<br/>Cohort Studies<br/>Disease Progression<br/>Europe<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Interferon beta-1a<br/>Interferon-beta--therapeutic use<br/>Magnetic Resonance Imaging<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Time Factors<br/>Treatment Outcome